Skip to content

Clinical trials

Completed Phase 4 Hyperlipidemias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Phase: Phase 4 Status: Completed Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20033
20044
20055
20061
20073
20082
20094
20105
20112
20121
20131
20141
20151
20165
20171
20181
20191
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
JW Pharmaceutical2
Takeda2
University of Colorado, Denver2
AstraZeneca1
Brigham and Women's Hospital1
Cynthia West1
Dong-A ST Co., Ltd.1
French National Agency for Research on AIDS and Viral Hepatitis1
Gottfried Wilhelm Leibniz Universität Hannover1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias46
Cardiovascular Diseases8
Diabetes Mellitus7
Hypercholesterolemia7
Dyslipidemias6
Hypertension6
Coronary Disease4
Diabetes Mellitus, Type 23
HIV Infections3
Hyperlipoproteinemia Type II3

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.